Sarcopenia
Welcome,         Profile    Billing    Logout  
 46 Companies   12 Products   12 Products   17 Mechanisms of Action   756 Trials   22406 News 


«12...137138139140141142143144145146147...401402»
  • ||||||||||  Journal:  Sarcopenia: investigation of metabolic changes and its associated mechanisms. (Pubmed Central) -  Jan 20, 2023   
    We observed a difference in the plasma metabolic profile in association with different measures of sarcopenia, which identifies very long-chain fatty acids, Carn.DC and citrulline as key variables associated with the disease severity. These findings point to a potential link between sarcopenia and mitochondrial dysfunction and portraits a number of possible biochemical pathways which might be involved in the disease pathogenesis.
  • ||||||||||  Trial completion, Trial primary completion date:  The Effect of Tai Chi Exercise Among Elders With Sarcopenia (clinicaltrials.gov) -  Jan 19, 2023   
    P=N/A,  N=60, Completed, 
    This study could provide some evidence for the application of n-3 PUFA in improving sarcopenia. Recruiting --> Completed | Trial primary completion date: Jul 2022 --> Apr 2022
  • ||||||||||  Review, Journal:  Sarcopenia in the Cirrhotic Patient: Current Knowledge and Future Directions. (Pubmed Central) -  Jan 18, 2023   
    This highlights the importance of identification of at-risk individuals with early nutritional, therapeutic and physical therapy intervention. This manuscript summarizes literature relevant to sarcopenia in cirrhosis, describes current knowledge, and elucidates possible future directions.
  • ||||||||||  Trial completion date, Trial primary completion date:  GoMob-in: Goal-directed Mobilization of Medical Inpatients (clinicaltrials.gov) -  Jan 18, 2023   
    P=N/A,  N=160, Recruiting, 
    This manuscript summarizes literature relevant to sarcopenia in cirrhosis, describes current knowledge, and elucidates possible future directions. Trial completion date: Dec 2022 --> May 2023 | Trial primary completion date: Sep 2022 --> Feb 2023
  • ||||||||||  Prolia (denosumab) / Amgen, Daiichi Sankyo
    Trial completion date, Trial primary completion date:  MITO: Muscle Impact of Treating Osteoporosis (clinicaltrials.gov) -  Jan 14, 2023   
    P4,  N=40, Not yet recruiting, 
    No abstract available Trial completion date: Jul 2023 --> Jul 2024 | Trial primary completion date: Jul 2023 --> Jul 2024